We are concerned that many MedTech companies have halted their product development plans because of COVID19 but this is exactly the time you need to be active so that when the economies are back up and running, you will be well ahead of your competitors.
What's the format? Free consulting consisting of 45-minute bite-sized sessions via our dedicated and secure GoToMeeting platform. These sessions aim to provide answers on any regulatory affairs questions that you may have in relation to MedTech products (medical devices, IVDs, combo devices and digital health) which you are developing and commercialising, whether or not these are related to the current COVID19 pandemic. The session is free and companies and entrepreneurs can use the time however you wish. Global Regulatory Services will be represented by Greer Deal, Director, and Dr Kieran Connole, Regulatory & Quality Compliance Specialist will be representing our Irish subsidiary, Med-Di-Dia.
These sessions represent a real opportunity to tap into our specific regulatory affairs and quality compliance expertise, as well as to potentially access our network of trusted complementary services such as IP, grant funding, pre-clinical, GDPR, market access and reimbursement.
Consulting slots are allocated on a ‘first come, first served’ basis. If you can't be available on the date suggested, please don't worry because we will be scheduling more of these sessions over the coming weeks and are already operating a waiting list for these.
We look forward to helping you plan your next regulatory steps, to do something proactive and valuable during these challenging times and get your fantastic, innovative products onto the market. With this gift of free regulatory consulting sessions, you might even think that Christmas has come early!